Back to trial details

Intake questionnaire

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

Applying to NEXT Oncology · San Antonio, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 89 years old?
2. Have you been diagnosed with Advanced Solid Tumors?
3. Are you able to travel to San Antonio for study visits?